Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-07-11Clinical Trial Update: An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular Hypertension
The registry entry indicates the observational study evaluating the ETX-4143 device for ocular hypertension has been withdrawn.
-
EMA withdrawal · 2024-12-17EMA Application withdrawn: Durysta (bimatoprost) — AbbVie Deutschland GmbH & Co. KG
The EMA has withdrawn the marketing authorization application for Durysta (bimatoprost) submitted by AbbVie Deutschland GmbH & Co. KG for op…
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Effect of Negative Pressure on Pattern Electroretinography Readings [NA]
A clinical trial examining the effect of negative pressure on pattern electroretinography readings in glaucoma-related conditions has been w…
-
CLINICAL_TRIALS withdrawal · 2024-03-04Clinical Trial Update: A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension [Phase 4]
A Phase 4 study evaluating latanoprostene bunod for ocular hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-04-07Clinical Trial Update: Pilocarpine After Combined Cataract/Trabectome Surgery [Phase 3]
Phase 3 trial of pilocarpine after combined cataract/trabectome surgery was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-11-19Clinical Trial Update: A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing SDP-133 (Sun Pharma) daily with Lumigan in open-angle glaucoma or ocular hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-02Clinical Trial Update: Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device [Phase 3]
Phase 3 trial evaluating safety and efficacy of Xalatan delivered by a conventional dropper bottle versus a delivery device was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-15Clinical Trial Update: The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. [Phase 4]
Phase 4 trial investigating secondary benefits of a prostaglandin analog in Thyroid Eye Disease was withdrawn; the study also referenced ocu…
-
CLINICAL_TRIALS withdrawal · 2016-05-13Clinical Trial Update: Intra-observer and Inter-observer Variability With Dynamic Contour Tonometry.
The clinical trial investigated intra- and inter-observer variability in dynamic contour tonometry for intraocular pressure measurements, bu…
-
CLINICAL_TRIALS withdrawal · 2015-07-09Clinical Trial Update: The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
A clinical trial evaluating the effect of omega-3 fatty acid supplementation on intraocular pressure and ocular surface in open-angle glauco…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH [Phase 3]
A Phase 3 trial comparing latanoprost/brinzolamide to latanoprost alone in open-angle glaucoma or ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-26Clinical Trial Update: Ocular Hypertension And Yoga Study [NA]
A Johns Hopkins University clinical trial evaluating yoga for ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-17Clinical Trial Update: A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
A Phase 2 trial evaluating a latanoprost punctal plug delivery system for ocular hypertension or open-angle glaucoma was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-18Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of a triple combination dorzolamide hydrochloride/brimonidine tartrate/timolol ophthalmic…
-
CLINICAL_TRIALS withdrawal · 2013-02-07Clinical Trial Update: Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia [Phase 4]
A Phase 4 clinical trial evaluating DuoTrav as replacement therapy for glaucoma and ocular hypertension in Russia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-10-18Clinical Trial Update: Travacom Post Marketing Surveillance Study [Phase 4]
A Phase 4 post-marketing surveillance study of Travacom for open-angle glaucoma and ocular hypertension has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-03-16Clinical Trial Update: The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) [NA]
This clinical trial update indicates the study comparing Cosopt (dorzolamide/timolol) and Xalacom (latanoprost/timolol) in open-angle glauco…
-
CLINICAL_TRIALS withdrawal · 2012-02-10Clinical Trial Update: Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% [Phase 3]
A Phase 3 study comparing TRAVATAN to Travoprost Ophthalmic Solution (0.004%) for open-angle glaucoma and ocular hypertension has been withd…
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Safety and Efficacy Study of DuoTrav APS Versus DuoTrav [Phase 3]
A Phase 3 safety and efficacy trial comparing DuoTrav APS to DuoTrav was withdrawn, involving open-angle glaucoma and ocular hypertension.